OneSource in talks to raise Rs 1,670 crore in pre-listing round
26 Sep 2024 //
ECONOMICTIMES
Stelis Biopharma updates on receipt of consideration from Syngene
25 Dec 2023 //
INDIAN PHARMA POST
Syngene concludes acquisition of biologics manufacturing facility from Stelis
03 Dec 2023 //
INDIAN PHARMA POST
Akston Biosciences Ends Vaccine Partnership with Stelis
07 Mar 2023 //
BUSINESSWIRE
Stelis Biopharma receives establishment inspection report from USFDA
18 Jan 2023 //
ECONOMIC TIMES
Stelis Biopharma requests PM Modi for procurement of jabs
14 May 2022 //
ECONOMIC TIMES
Stelis Biopharma Appoints Mark Womack as CEO
06 Aug 2021 //
CONTRACTPHARMA
Stelis Concludes Fundraise Worth $195 Million
25 Mar 2021 //
PHARMTECH
RDIF & Stelis Biopharma to supply 200 million doses of the Sputnik V vaccine
19 Mar 2021 //
PHARMAFILE
Strides re-enters injectable biz, to take controlling stake in Stelis Biopharma
20 Sep 2019 //
MONEYCONTROL